Globus Medical Q1 2026 Results: U.S. Spine Market Share Growth Insights
Globus Medical reported a 10% growth in U.S. Spine during Q1 2026, driven by market share gains and strategic execution, surpassing industry market growth.
Read postDetailed company information
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 06, 2026
Earnings Transcript for 2026 - Q1Released: May 07, 2026
Earnings Transcript for 2025 - Q4Released: Feb 24, 2026
Earnings Transcript for 2025 - Q3Released: Nov 06, 2025
Earnings Transcript for 2025 - Q2Released: Aug 08, 2025
Earnings Transcript for 2025 - Q1Released: May 08, 2025
Earnings Transcript for 2024 - Q4Released: Feb 20, 2025
Earnings Transcript for 2024 - Q3Released: Nov 05, 2024
Earnings Transcript for 2024 - Q2Released: Aug 06, 2024
Earnings Transcript for 2024 - Q1Released: May 07, 2024
Earnings Transcript for 2023 - Q4Released: Feb 20, 2024
Earnings Transcript for 2023 - Q3Released: Nov 07, 2023
Earnings Transcript for 2023 - Q2Released: Aug 03, 2023
Earnings Transcript for 2023 - Q1Released: May 04, 2023
Earnings Transcript for 2022 - Q4Released: Feb 21, 2023
Earnings Transcript for 2022 - Q3Released: Nov 08, 2022
Earnings Transcript for 2022 - Q2Released: Aug 04, 2022
Earnings Transcript for 2022 - Q1Released: May 10, 2022
Earnings Transcript for 2021 - Q4Released: Feb 17, 2022
Earnings Transcript for 2021 - Q3Released: Nov 04, 2021
Earnings Transcript for 2021 - Q2Released: Aug 04, 2021
Earnings Transcript for 2021 - Q1Released: May 04, 2021
Earnings Transcript for 2020 - Q4Released: Feb 17, 2021
Earnings Transcript for 2020 - Q3Released: Oct 28, 2020
OFIX Orthofix Medical Inc.
ATEC Alphatec Holdings, Inc.
GKOS Glaukos Corporation
ITGR Integer Holdings Corporation
CNMD CONMED Corporation
IRTC iRhythm Technologies, Inc.
LIVN LivaNova PLC
INSP Inspire Medical Systems, Inc.
BRKR Bruker Corporation
NVCR Novocure Ltd
PODD Insulet Corp.
BSX Boston Scientific Corporation
Globus Medical reported a 10% growth in U.S. Spine during Q1 2026, driven by market share gains and strategic execution, surpassing industry market growth.
Read postGlobus Medical plans a strategic shift towards increased operating lease placements in Enabling Technologies for 2026, impacting revenue recognition and gross margins. This approach balances short-term revenue timing effects with long-term growth through implant pull-through and operational efficiency.
Read post